Clinical trial
Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal
NCT00011297 · National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH · Completed
Key facts
| NCT number | NCT00011297 |
|---|---|
| Title | Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal |
| Official title | Alcohol Research Center - Treatment and Implications |
| Lead sponsor | National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcoholism |
| Intervention type | Drug |
| Interventions | gabapentin (Neurontin), lorazepam (Ativan) |
| Enrollment | 160 |
| Completion | Dec 1, 2005 |
| First posted | Feb 19, 2001 |
| Last update posted | Oct 23, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: